Kezar Life Sciences
81 hedge funds and large institutions have $47M invested in Kezar Life Sciences in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.8% less ownership
Funds ownership: 7.63% → 6.83% (-0.8%)
1% less funds holding
Funds holding: 82 → 81 (-1)
29% less capital invested
Capital invested by funds: $66M → $47M (-$19M)
Holders
81
Holding in Top 10
1
Calls
$179K
Puts
$6K
Top Buyers
| 1 | +$647K | |
| 2 | +$627K | |
| 3 | +$618K | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$579K |
| 5 |
Two Sigma Investments
New York
|
+$510K |
Top Sellers
| 1 | -$3.35M | |
| 2 | -$1.62M | |
| 3 | -$1.33M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$934K |
| 5 |
Goldman Sachs
New York
|
-$893K |